{
  "pmcid": "5244530",
  "raw_text": "```json\n[\n  {\n    \"pmcid\": null,\n    \"outcome\": \"remission rate\",\n    \"intervention\": \"person-centred general practitioners (GP) consultations using MADRS-S\",\n    \"comparator\": \"treatment as usual (TAU)\",\n    \"outcome_type\": \"binary\",\n    \"intervention_events\": 61,\n    \"intervention_group_size\": 125,\n    \"comparator_events\": 63,\n    \"comparator_group_size\": 133,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null,\n    \"notes\": \"Remission defined as BDI-II score \u226413 at 3-month follow-up. Text reports 49% remission in intervention and 47.3% in TAU; event counts calculated as 0.49*125 and 0.473*133 and rounded to nearest whole number.\",\n    \"pmcid\": null\n  },\n  {\n    \"pmcid\": null,\n    \"outcome\": \"sedative prescriptions\",\n    \"intervention\": \"person-centred general practitioners (GP) consultations using MADRS-S\",\n    \"comparator\": \"treatment as usual (TAU)\",\n    \"outcome_type\": \"binary\",\n    \"intervention_events\": 52,\n    \"intervention_group_size\": 125,\n    \"comparator_events\": 51,\n    \"comparator_group_size\": 133,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null,\n    \"notes\": \"From Table 2: at 12-month follow-up, 52/125 (42%) in intervention and 51/133 (38%) in TAU had prescriptions for sedatives.\",\n    \"pmcid\": null\n  },\n  {\n    \"pmcid\": null,\n    \"outcome\": \"sick leave\",\n    \"intervention\": \"person-centred general practitioners (GP) consultations using MADRS-S\",\n    \"comparator\": \"treatment as usual (TAU)\",\n    \"outcome_type\": \"continuous\",\n    \"intervention_events\": null,\n    \"intervention_group_size\": 125,\n    \"comparator_events\": null,\n    \"comparator_group_size\": 133,\n    \"intervention_mean\": 124.8,\n    \"intervention_standard_deviation\": 102.5,\n    \"comparator_mean\": 123.3,\n    \"comparator_standard_deviation\": 85.0,\n    \"notes\": \"From Table 3: mean total duration of sick leave (days) over 0\u201312 months among those with any sick leave. Number of individuals with sick leave: 49 (39%) intervention, 64 (48%) TAU. Group sizes for the trial were 125 and 133, respectively.\",\n    \"pmcid\": null\n  },\n  {\n    \"pmcid\": null,\n    \"outcome\": \"continued antidepressants until the 6-month\",\n    \"intervention\": \"person-centred general practitioners (GP) consultations using MADRS-S\",\n    \"comparator\": \"treatment as usual (TAU)\",\n    \"outcome_type\": \"binary\",\n    \"intervention_events\": 86,\n    \"intervention_group_size\": 125,\n    \"comparator_events\": 78,\n    \"comparator_group_size\": 133,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null,\n    \"notes\": \"From abstract and Table 2: at 6-month follow-up, 86/125 (69%) in intervention vs 78/133 (59%) in TAU were on antidepressants.\",\n    \"pmcid\": null\n  },\n  {\n    \"pmcid\": null,\n    \"outcome\": \"depression severity reduction 12 months\",\n    \"intervention\": \"person-centred general practitioners (GP) consultations using MADRS-S\",\n    \"comparator\": \"treatment as usual (TAU)\",\n    \"outcome_type\": \"continuous\",\n    \"intervention_events\": null,\n    \"intervention_group_size\": 125,\n    \"comparator_events\": null,\n    \"comparator_group_size\": 133,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null,\n    \"notes\": \"Outcome measured with BDI-II. Article reports no significant difference in mean intra-individual change between groups at 12 months, but exact means/SDs are not provided in text or tables.\",\n    \"pmcid\": null\n  },\n  {\n    \"pmcid\": null,\n    \"outcome\": \"change in quality of life 12 months\",\n    \"intervention\": \"person-centred general practitioners (GP) consultations using MADRS-S\",\n    \"comparator\": \"treatment as usual (TAU)\",\n    \"outcome_type\": \"continuous\",\n    \"intervention_events\": null,\n    \"intervention_group_size\": 125,\n    \"comparator_events\": null,\n    \"comparator_group_size\": 133,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null,\n    \"notes\": \"Outcome measured with EQ-5D. Article states no significant differences in mean intra-individual change between groups at 12 months; exact numeric values not reported.\",\n    \"pmcid\": null\n  },\n  {\n    \"pmcid\": null,\n    \"outcome\": \"psychological well-being\",\n    \"intervention\": \"person-centred general practitioners (GP) consultations using MADRS-S\",\n    \"comparator\": \"treatment as usual (TAU)\",\n    \"outcome_type\": \"continuous\",\n    \"intervention_events\": null,\n    \"intervention_group_size\": 125,\n    \"comparator_events\": null,\n    \"comparator_group_size\": 133,\n    \"intervention_mean\": null,\n    \"intervention_standard_deviation\": null,\n    \"comparator_mean\": null,\n    \"comparator_standard_deviation\": null,\n    \"notes\": \"Outcome measured with GHQ-12. Figures show trajectories but no exact means/SDs; text reports no significant differences in mean intra-individual change between groups over 12 months.\",\n    \"pmcid\": null\n  }\n]\n```",
  "extraction": [
    {
      "pmcid": null,
      "outcome": "remission rate",
      "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
      "comparator": "treatment as usual (TAU)",
      "outcome_type": "binary",
      "intervention_events": 61,
      "intervention_group_size": 125,
      "comparator_events": 63,
      "comparator_group_size": 133,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "notes": "Remission defined as BDI-II score \u226413 at 3-month follow-up. Text reports 49% remission in intervention and 47.3% in TAU; event counts calculated as 0.49*125 and 0.473*133 and rounded to nearest whole number."
    },
    {
      "pmcid": null,
      "outcome": "sedative prescriptions",
      "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
      "comparator": "treatment as usual (TAU)",
      "outcome_type": "binary",
      "intervention_events": 52,
      "intervention_group_size": 125,
      "comparator_events": 51,
      "comparator_group_size": 133,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "notes": "From Table 2: at 12-month follow-up, 52/125 (42%) in intervention and 51/133 (38%) in TAU had prescriptions for sedatives."
    },
    {
      "pmcid": null,
      "outcome": "sick leave",
      "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
      "comparator": "treatment as usual (TAU)",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 125,
      "comparator_events": null,
      "comparator_group_size": 133,
      "intervention_mean": 124.8,
      "intervention_standard_deviation": 102.5,
      "comparator_mean": 123.3,
      "comparator_standard_deviation": 85.0,
      "notes": "From Table 3: mean total duration of sick leave (days) over 0\u201312 months among those with any sick leave. Number of individuals with sick leave: 49 (39%) intervention, 64 (48%) TAU. Group sizes for the trial were 125 and 133, respectively."
    },
    {
      "pmcid": null,
      "outcome": "continued antidepressants until the 6-month",
      "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
      "comparator": "treatment as usual (TAU)",
      "outcome_type": "binary",
      "intervention_events": 86,
      "intervention_group_size": 125,
      "comparator_events": 78,
      "comparator_group_size": 133,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "notes": "From abstract and Table 2: at 6-month follow-up, 86/125 (69%) in intervention vs 78/133 (59%) in TAU were on antidepressants."
    },
    {
      "pmcid": null,
      "outcome": "depression severity reduction 12 months",
      "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
      "comparator": "treatment as usual (TAU)",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 125,
      "comparator_events": null,
      "comparator_group_size": 133,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "notes": "Outcome measured with BDI-II. Article reports no significant difference in mean intra-individual change between groups at 12 months, but exact means/SDs are not provided in text or tables."
    },
    {
      "pmcid": null,
      "outcome": "change in quality of life 12 months",
      "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
      "comparator": "treatment as usual (TAU)",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 125,
      "comparator_events": null,
      "comparator_group_size": 133,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "notes": "Outcome measured with EQ-5D. Article states no significant differences in mean intra-individual change between groups at 12 months; exact numeric values not reported."
    },
    {
      "pmcid": null,
      "outcome": "psychological well-being",
      "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
      "comparator": "treatment as usual (TAU)",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 125,
      "comparator_events": null,
      "comparator_group_size": 133,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "notes": "Outcome measured with GHQ-12. Figures show trajectories but no exact means/SDs; text reports no significant differences in mean intra-individual change between groups over 12 months."
    }
  ],
  "usage": {
    "input": 0,
    "output": 0
  },
  "model": "gpt",
  "strategy": "zero-shot",
  "temperature": 0.0
}